Lorlatinib
CAS: 1454846-35-5
Ref. TM-T3061
| 1g | 878.00 € | ||
| 2mg | 46.00 € | ||
| 5mg | 67.00 € | ||
| 10mg | 99.00 € | ||
| 25mg | 147.00 € | ||
| 50mg | 225.00 € | ||
| 100mg | 393.00 € | ||
| 1ml*10 (DMSO) | 68.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Product Information
Name:
Lorlatinib
Synonyms:
- PF-6463922, PF-06463922, Loratinib
- (10R)-7-Amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-2H-4,8-methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile
- 2H-4,8-Methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile, 7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-, (10R)-
- Loratinib
- Lorbrena
- Lorviqua
- Pf0643922
CAS:
Description:
Lorlatinib (PF-6463922) is an orally available, ATP-competitive inhibitor of the receptor tyrosine kinases, anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1), with potential antineoplastic activity.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
406.41
Formula:
C21H19FN6O2
Purity:
99.93%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T3061 Lorlatinib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
